Tactile Systems Technology (TCMD) Akcie Kurz

Tactile Systems Technology Kurz

NASDAQ·UZAVŘENO
23,04
​
Trh uzavřen

Tržby rostly o 19,9 % ročně za posledních 12 let na 329,52 Mil. USD. Zisk na akcii klesal o 3,8 % ročně za posledních 12 let. čistá marže společnosti Tactile Systems Technology je nyní 5,8 %, nahoru z -5,7 % před několika lety. Medián cílové ceny analytiků je 40,00 USD, tedy nad aktuální cenu o 73,6 %. Z 10 analytiků jich 9 doporučuje nákup — celkový konsenzus je Koupit.

Cena akcie Tactile Systems Technology

Tato data přes Eulerpool API

100 000 požadavků/měs. zdarma · bez karty

Obchodní model Tactile Systems Technology a analýza akcií

Tactile Systems Technology Inc. je americká společnost zaměřená na zdravotnické technologie, která vyrábí inovativní terapeutické přístroje pro léčbu periferie arteriální nemoci (PAD) a lymfatických onemocnění. Společnost byla založena v roce 1995 Geraldem R. Mattysm a má sídlo v Minneapolis ve státě Minnesota.

Nejčastější otázky týkající se akcie Tactile Systems Technology

Tactile Systems Technology Inc is a medical technology company specializing in the development and commercialization of innovative medical devices to treat chronic diseases. Their business model focuses on providing cost-effective and patient-centered solutions for the management of lymphedema and other vascular conditions. By offering advanced and wearable compression therapy products, Tactile Systems aims to improve patients' quality of life and medical outcomes. With a strong emphasis on research and development, they continuously strive to enhance their product portfolio and expand their market reach. Tactile Systems' commitment to innovative healthcare solutions positions them as a leading player in the medical technology industry.

Tactile Systems Technology Inc is primarily active in the healthcare industry.

The main competitors of Tactile Systems Technology Inc in the market include companies such as Medtronic, Smith & Nephew, Hill-Rom Holdings, and Acelity.

Tactile Systems Technology Inc, commonly known as Tactile Medical, is a leading medical technology company based in Minneapolis, Minnesota. Founded in 1995, the company specializes in developing and providing at-home therapy devices and solutions for the treatment of lymphedema and chronic venous insufficiency. Tactile Medical's mission is to advance patient care by addressing unmet medical needs through innovative products and services. With its cutting-edge technology and dedication to improving patients' quality of life, Tactile Medical has become a trusted name in the medical community. Despite its relatively young age, the company has achieved significant growth and recognition, making it a promising investment option for those interested in the medical technology sector.

Tactile Systems Technology Inc has achieved several significant milestones. One notable accomplishment is its successful initial public offering in July 2016, which enabled the company to raise funds for future growth and expansion. Additionally, Tactile Systems has developed and launched innovative medical devices, including its Flexitouch system for lymphedema management. The company has received multiple awards and recognition for its contributions to the healthcare industry, such as being named to the Forbes 2017 list of America's Best Small Companies. Tactile Systems Technology Inc continues to focus on advancing patient care through its advanced medical solutions and dedication to innovation.

Tactile Systems Technology Inc is primarily present in the United States.

Tactile Systems Technology Inc is a leading medical technology company that specializes in developing and providing at-home therapy solutions. Their core values include patient-centricity, innovation, integrity, and collaboration. With a focus on improving the lives of patients with chronic diseases, Tactile Systems Technology Inc is dedicated to developing high-quality products that offer comfort and convenience. The company's corporate philosophy revolves around delivering effective and personalized healthcare solutions through a comprehensive understanding of patient needs. Tactile Systems Technology Inc consistently prioritizes patient well-being and strives to enhance their quality of life through continuous advancements in medical technology and patient care.

Analytici aktuálně stanovují průměrnou cílovou cenu 40,00 USD pro akcii Tactile Systems Technology (medián: 40,00 USD), tedy +73,6 % vůči poslední ceně. Konsensus vychází z 10 hodnocení analytiků.

10 analytiků aktuálně hodnotí akcii Tactile Systems Technology: 9 doporučuje koupit, 1 držet a 0 prodat. Pro rok 2026 analytici očekávají u Tactile Systems Technology tržby 362,39 Mil. USD a zisk na akcii 1,08 USD.

Při aktuálním kurzu se akcie Tactile Systems Technology obchoduje za 20,58 EUR (23,04 USD).

Akcie Tactile Systems Technology (TCMD) je kótována na 3 burzách, mimo jiné: NASDAQ (TCMD), Frankfurt (3L3.F), München (3L3.MU).

The company Tactile Systems Technology Inc is a US-American company based in Minneapolis that specializes in the development and distribution of medical devices for the treatment of peripheral circulation disorders. The company's business model is based on a wide range of non-invasive therapy devices that are used by patients to treat circulation disorders in the lower extremities. The Tactile product portfolio includes a range of devices, from light compression stockings to advanced systems with more comprehensive functions and applications. Tactile devices have been designed to improve circulation and support the healing of chronic wounds or injuries caused by poor circulation. The therapy devices are based on a patented technological approach - a unique pneumatic system that applies pulsating pressure to the lower extremities to improve circulation and reduce edema. The devices are designed to meet a variety of patient needs and can be used both in a clinical setting and at home. In addition to its therapy devices, Tactile also offers a range of services to support patients in the effective use of the devices and improve outcomes. These include patient and medical professional training programs, support services, and data analysis tools to ensure optimal therapy. The market for peripheral circulation disorders and chronic wounds is large and growing. According to estimates from the American Heart Association, more than 8.5 million people in the United States alone suffer from circulation disorders in the lower extremities, and this number is expected to continue rising due to factors such as increasing age and lifestyle diseases like diabetes. Tactile has managed to establish itself as a market leader in this segment by providing innovative products and services tailored to the needs of patients and medical professionals. The company has built a strong brand and made its products popular among doctors and clinics in the US. It also has a strong presence in the international market and has successfully expanded into new regions. Overall, Tactile offers its customers an integrated system of therapy devices and services aimed at improving the treatment of circulation disorders and maximizing patient outcomes. With its proven business model, strong brand presence, and commitment to product innovation and quality, Tactile is well positioned to continue growing successfully and increase its market share.

Tržby očekávané za Tactile Systems Technology činí 362,39 Mil. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.

Zisk očekávané za Tactile Systems Technology činí 24,95 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.

Poměr ceny k zisku (P/E) Tactile Systems Technology je aktuálně 21,28. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Tactile Systems Technology.

Poměr ceny k tržbám (P/S) Tactile Systems Technology je aktuálně 1,47. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Tactile Systems Technology.

Score kvality pro Tactile Systems Technology je 5/10.

ISIN Tactile Systems Technology je US87357P1003. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.

WKN Tactile Systems Technology je A2APEV. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.

Ticker Tactile Systems Technology je TCMD. Symbol tickeru se používá k obchodování akcií Tactile Systems Technology na burze.

Spravedlivá hodnotaTerminal
21,20 USD
Nadhodnocení/PodhodnoceníTerminal
Férovně oceněno
Průmysl
Zdravotnické zařízení a zásobování
Počet akcií
Zaměstnanci
Tržby na zaměstnance
303 427,26 USD
Růst tržeb Ø5 let
Růst EBIT Ø5 let
Růst čistého příjmu Ø5 let
Webové stránky tactilemedical.com
Měna
USD
Veřejná nabídka akcií
28. 7. 2016
ISIN
US87357P1003
CUSIP
87357P100
SEDOL
BZB1XF2
Tržní kapitalizace
52týdenní rozpětí
PEG
1,15
P/E poměr
P/E poměr 2026
20,63
P/E poměr 2027
15,03
P/E poměr 2028
10,77
P/S
P/S poměr
1,47
EV/EBIT
14,84
P/B ratio
2,35
ROE (návratnost vlastního kapitálu)
ROA (návratnost aktiv)
ROCE (návratnost použitého kapitálu)
ROIC (návratnost investovaného kapitálu)
8,59 %
Poslední aktualizace 3. 11. 2026 3:44

Tactile Systems Technology Ticker

FRANKFURT · 3L3.FMNICHOV · 3L3.MUNASDAQ · TCMD

Tactile Systems Technology FIGI

TCMD:US · BBG001B12Z39TCMD:UA · BBG00C0BG466TCMD:UC · BBG00C0BG475TCMD:UN · BBG00C0BG493TCMD:UP · BBG00C0BG4B0TCMD:UQ · BBG00C0BG4C9TCMD:UB · BBG00C0BG4D8TCMD:UM · BBG00C0BG4G5TCMD:UX · BBG00C0BG4H4TCMD:UD · BBG00C0BG4N7TCMD:UF · BBG00C0BG4R3TCMD:VY · BBG00C0BG4S2

Všechny fundamentální údaje o Tactile Systems Technology v podrobné analýze

Naše analýzy akcií společnosti Tactile Systems Technology zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Tactile Systems Technology. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: